AOD-9604 5mg

AOD-9604 is a synthetic peptide developed as a modified fragment of human growth hormone that, in a research context, attracts interest for its targeted influence on fat metabolism. It contains the active part of the growth hormone molecule associated with lipolytic action, without significant activation of the classical hormonal pathways related to growth, IGF-1 and tissue regeneration. It is precisely this selectivity that positions it as a molecule focused on body composition, energy balance and metabolic research.

What is AOD-9604?

AOD-9604 is a modified and optimized variant of HGH Fragment 176-191, created specifically for fat burning, with a more focused and refined effect. HGH Fragment has broader activity, while AOD-9604 is primarily directed at lipolysis and control of adipose tissue.

The peptide was developed to isolate and utilize the lipolytic effect of growth hormone without activating its other functions related to growth and tissue regeneration.

AOD-9604 acts by stimulating the breakdown of fat (lipolysis) while simultaneously suppressing the formation of new fat cells (lipogenesis). This makes it extremely interesting in studies related to weight control and metabolism.

The peptide was originally developed as a potential means to combat obesity and metabolic disorders, and in several studies has shown the ability to assist in reducing body fat.

AOD-9604 is used for goals related to fat reduction and improving body composition.

The peptide is not approved as a medicinal product by the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) and is used only in scientific and research settings.

What are the benefits of AOD-9604?

• Fat burning

AOD-9604 stimulates lipolysis and helps break down adipose tissue.

• Suppression of fat accumulation

It limits processes related to the formation of new fat cells.

• Improvement of metabolism

It is associated with more efficient use of fats as an energy source.

• Preservation of muscle mass

It does not directly affect muscle growth but supports fat loss without muscle loss.

• Improvement of body composition

It is associated with a better balance between fat mass and lean mass.

• Support in weight reduction

It is used in studies related to obesity and weight control.

Clinical trials on AOD-9604

AOD-9604 is the subject of numerous studies aimed at its effect on body fat and metabolism.

In one of the larger clinical trials with overweight participants, a significant reduction in fat tissue was observed with the administration of AOD-9604, without changes in blood glucose levels or insulin sensitivity. This is a key difference compared to classical growth hormone.

Data from studies show that the peptide stimulates lipolysis and suppresses lipogenesis, while not affecting IGF-1 and not leading to the hormonal side effects typical of GH.

Additional observations report good tolerability and the absence of serious adverse reactions, which makes AOD-9604 suitable for long-term protocols aimed at weight control and improvement of body composition.

Correct administration and dosing of AOD-9604 within a research protocol

AOD-9604 is typically administered by subcutaneous injection, with doses most commonly used in research protocols ranging from 300 to 500 mcg daily.

In scientific observations the peptide is used in regimens aimed at activating lipolysis, with its effect most pronounced when administered under conditions of low insulin levels.

For this reason AOD-9604 is often administered in the morning on an empty stomach or before physical activity, when the body is in a more favorable state for using fats as an energy source. Food intake, especially carbohydrates, can reduce the lipolytic effect.

Research protocols use both daily schemes and cyclical approaches, depending on objectives and observed response.

The duration of administration usually varies between 4 and 12 weeks, with longer protocols monitoring the effect on body composition and metabolism.

Possible side effects of AOD-9604

AOD-9604 is considered a well-tolerated peptide, and to date there is no serious evidence of severe side effects with proper use.

In rare cases, mild redness at the injection site or slight discomfort may be observed.

Comparison of AOD-9604 with other peptides

AOD-9604 belongs to the group of metabolically targeted peptides and is distinguished by its focus on adipose tissue, lipolysis and body composition.

AOD-9604 vs HGH Fragment 176-191

HGH Fragment 176-191 denotes the C-terminal fragment of the growth hormone molecule from which the concept of AOD-9604 originates. In practice the two terms are often used interchangeably, but AOD-9604 is a pharmaceutically optimized version intended for better stability and application in a research context.

AOD-9604 vs HGH (Somatotropin)

Human Growth Hormone (HGH) affects the whole organism through IGF-1, recovery, muscle growth and metabolism. AOD-9604 does not aim for a systemic GH effect and does not significantly activate classical growth pathways, being primarily directed at fat metabolism.

AOD-9604 vs CJC-1295 / Ipamorelin

CJC-1295 and Ipamorelin stimulate the body's own release of growth hormone through different receptor mechanisms. This can lead to broader effects on recovery, sleep, IGF-1 and body composition. AOD-9604 is more narrowly focused on fat reduction without relying on a GH peak.

AOD-9604 vs 5-Amino-1MQ

5-Amino-1MQ is not a peptide but a metabolic compound associated with NAMPT pathways, energy balance and fat metabolism. AOD-9604 works by a different mechanism, but both molecules are often considered in the context of body composition and fat control.

AOD-9604 vs MOTS-c

MOTS-c is a mitochondrial peptide more directed at insulin sensitivity, cellular energy and metabolic flexibility. AOD-9604 is more directly associated with lipolysis and adipose tissue, while MOTS-c has a broader cellular-metabolic profile.

The information on this website has been collected and summarized from multiple scientific studies and analyses.

It is entirely informational in nature and is not intended for diagnosis, treatment or prevention of diseases.

The products offered on the site are not classified as medicines or medical devices and are suitable only for laboratory and scientific research purposes.